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Abstract
Background: The aim of this study was to compare the socioeconomic profile of patients undergoing
liver resection for colorectal liver metastasis (CLM) in a regional hepatopancreatobiliary unit with that of
the local population. A further aim was to determine if degree of deprivation is associated with tumour
recurrence after resection.
Methods: A retrospective analysis of patients undergoing liver resection for CLM was performed.
Geodemographic segmentation was used to divide the population into five categories of socioeconomic
status (SES).
Results: During a 7-year period, 303 patients underwent resection for CLM. The proportion of these
patients in the two least deprived categories of SES was greater than that of the local population (50.2%
versus 40.2%) and the proportion in the two most deprived categories was lower (18.3% versus 30.1%)
(P < 0.001). There was no difference in recurrence rate (P = 0.867) or disease-free survival among
categories of SES (P = 0.913). Multivariate analysis demonstrated no association between SES and
tumour recurrence (P = 0.700).
Conclusions: Liver resection for CLM is performed more commonly among the least socioeconomically
deprived population than among the most deprived. However, degree of deprivation was not associated
with tumour recurrence after resection.
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Introduction
The incidence of primary colorectal cancer is associated with
low socioeconomic status (SES) in the UK, where the age-
standardized incidence is 11% higher in men living in the most
deprived areas of England compared with those living in the least
deprived,1 although no difference has been demonstrated in
women. Similar associations have been found in the USA, where
individuals with higher levels of deprivation have been found to
have a greater risk for the development of colorectal cancer even
when other risk factors are controlled for.2 Population studies
have also shown that low SES is associated with a worse outcome
amongst patients with colorectal cancer.3–5 Approximately a
quarter of patients with colorectal cancer will develop colorectal
liver metastases (CLM) at the time of presentation6 and a further
25–30% will develop CLM within 2–3 years of diagnosis.7 Little is
known of the impact of SES on the risk for CLM and on outcomes
of liver resection: a single UK study demonstrated no association
between social class and longterm outcome following resection.8
However, this study did not account for potential bias caused by
patient selection for liver surgery. Patients with primary colorectal
cancer often present symptomatically and are at risk of colonic
obstruction, and population studies have shown that 60–80% of
patients with primary colorectal cancer will be offered surgery.9
However, the proportion of patients with CLM who are offered
surgery is far lower, at 10–20%.10,11 Patients who develop CLM
must overcome a number of potential obstacles before undergo-
ing liver surgery. They must survive surgery for primary colorectal
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cancer; they require longterm surveillance imaging to detect
metachronous lesions; they must be referred to a hepatobiliary
unit; they must be medically fit for surgery, and their metastases
must be technically resectable. Socioeconomic factors may influ-
ence a patient’s ability to overcome these obstacles following
surgery for primary colorectal cancer, which may potentially skew
the population of patients submitted to surgery for CLM in com-
parison with that of the population suffering primary colorectal
cancer. A crude comparison of outcomes according to SES may
therefore be less valid for CLM as patients may be more strin-
gently selected than those undergoing surgery for primary
colorectal cancer.
The primary aim of this study was to compare levels of socio-
economic deprivation in patients undergoing liver resection for
CLM in a regional hepatopancreatobiliary (HPB) unit with those
of the local population. A secondary aim was to determine if SES
is associated with disease-free and overall survival.
Materials and methods
A retrospective analysis of a prospectively maintained database of
all patients submitted to liver resection for CLM between July
2005 and March 2012 was undertaken. Patient details, laboratory
data and operative details were retrieved. Synchronous metastases
were defined as those diagnosed prior to or within 2 months of
primary surgery. All patients underwent tumour staging with
computed tomography (CT) prior to liver surgery. Preoperative
magnetic resonance imaging (MRI) and positron emission
tomography (PET) scans were performed at the discretion of the
referring clinician. The physiological score was calculated using
the POSSUM (physiological and operative severity score for the
enumeration of mortality and morbidity) scoring system.12 Post-
operative surveillance CT scans were performed at 6-monthly
intervals for 3 years after liver resection and annually for another
2 years. All patients included in disease-free survival analyses
underwent a minimum of one surveillance CT scan and the date
of tumour recurrence was recorded.
Socioeconomic status was calculated using ACORN®,13 a com-
mercially available geodemographic segmentation tool. This tool
divides UK households into five categories in order of increasing
deprivation, characterized as representing: wealthy achievers;
the urban prosperous; the comfortably off; those of moderate
means, and the hard-pressed. The smallest unit of population for
which information is available is based on postcode. Full post-
codes allow an accurate geographical breakdown because the
median size of a residential postcode in the UK is 13 households
or 31 residents.13 The deprivation category is based on data col-
lected from multiple sources including property value, type,
occupancy and usage. Further information relating to residents
is obtained and includes data on date of birth, ethnicity and
receipt of social benefits, along with data on spending habits and
lifestyle. Population density data are obtained from the National
Census.
Patient survival curves were constructed using the Kaplan–
Meier method and differences in survival were assessed using the
log-rank method. Patients were excluded from survival analyses
if they underwent planned non-curative resections or did not
receive surveillance imaging. Comparisons between groups
according to SES were performed using the chi-squared test or
Mann–Whitney U-test, as appropriate. Potential associations
between pre- and intraoperative factors, as well as histological
outcome and tumour recurrence, were tested using univariate
logistic regression or the chi-squared test, as appropriate. Variables
in the univariate analysis for which differences achieved a P-value
of <0.25 were included in the multivariate regression model.14
Differences were considered to be significant at P < 0.05.
Univariate and multivariate analyses were carried out using R
Version 2.1.14.15
Patient consent was not required for this study following con-
firmation from the South West Health Research Authority that
under the harmonized Guidance Approval for Research Ethics
Committees (RECs), REC review is not required because patient
data were collected in the course of normal hospital care and were
anonymized for research purposes.
Results
Data relating to 303 liver resections performed for CLM over a
period of 7 years were analysed. Clinicopathological characteris-
tics and operative details of the group are displayed in Table 1. The
proportions of residents of Devon and Cornwall in the first and
second (least deprived) (40.2%) and fourth and fifth (most
deprived) (30.1%) SES categories differed from those of the UK
(37.4% and 35.1%, respectively) (P < 0.001) (Table 2). Socioeco-
nomic data were unavailable for eight patients undergoing liver
resection, leaving 295 for analysis. Of these 295 patients submitted
to liver resection for CLM, the proportions of patients from the
first and second (least deprived) categories (50.2%) and fourth
and fifth (most deprived) categories (18.3%) of SES differed from
the proportions in the local population (40.2% and 30.1%, respec-
tively) (P < 0.001).
The clinicopathological and operative characteristics of the 148
least deprived (categories 1 and 2) and 54 most deprived (catego-
ries 4 and 5) patients are displayed in Table 3. The use of PET
scans was greater in the least deprived than in the most deprived
group (75.0% versus 46.3%) and the proportion of patients with
American Society of Anesthesiologists (ASA) class 1 status was
higher in the least deprived (10.8%) compared with the most
deprived (1.9%) group.
Data for 18 patients were excluded from the disease-free sur-
vival analysis because their resections were non-curative or they
did not complete a staged resection. Data for a further 11 patients
were excluded because these patients died without undergoing
surveillance imaging. This left a total of 266 patients for analysis.
The median length of follow-up was 1.07 years (range: 0.14–6.59
years) in the least deprived categories and 1.14 years (range:
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Table 1 Preoperative and operative characteristics of 303 patients undergoing liver resection for colorectal liver metastases
Value
Age, years, median (range) 67 (33–90)
Gender, n (%) Female 113 (37.3%)
Male 190 (62.7%)
T stage of primary, n (%) 0 3 (< 1%)
1 7 (2.3%)
2 19 (6.3%)
3 174 (57.4%)
4 91 (30.0%)
Unavailable 9 (3.0%)
N stage of primary, n (%) 0 133 (43.9%)
1 101 (33.3%)
2 64 (21.1%)
Unavailable 5 (1.7%)
Site of primary, n (%) Colonic 152 (50.2%)
Rectal 151 (49.8%)
Timing, n (%) Synchronous 144 (47.5%)
Metachronous 159 (52.5%)
Preoperative MRI, n (%) Yes 166 (54.8%)
No 137 (45.2%)
Preoperative PET, n (%) Yes 208 (68.6%)
No 95 (31.4%)
Preoperative liver-directed chemotherapy, n (%) Yes 151 (49.8%)
No 152 (50.2%)
Preoperative diabetes, n (%) Yes 28 (9.2%)
No 275 (90.8%)
BMI, kg/m2, median (range) 27 (16–54)
ASA class, n (%) 1 24 (7.9%)
2 211 (69.6%)
3 68 (22.4%)
Neutrophil : lymphocyte ratio, median (range) 2.58 (0.50–17.25)
Preoperative albumin, g/dl, median (range) 44 (26–52)
POSSUM physiological score, median (range) 16 (12–32)
Operation, n (%) Right hemihepatectomy 129 (42.6%)
Extended right 13 (4.3%)
Left hemihepatectomy 35 (11.6%)
Extended left 3 (1.0%)
Left lateral sectorectomy 31 (10.2%)
Wedge resection 79 (26.1%)
Other 13 (4.3%)
RFA included, n (%) Yes 19 (6.3%)
No 284 (93.7%)
Wedge resection included, n (%) Yes 122 (40.3%)
No 181 (59.7%)
Number of segments resected, median (range) 4 (1–6)
Repeat operation, n (%) Yes 33 (10.9%)
No 270 (89.1%)
Curative resection, n (%) Yes 284 (93.7%)
No 19 (6.3%)
Number of tumours, median (range) 1 (1–10)
Maximum tumour diameter, mm, median (range) 35 (3–155)
Resection margin, n (%) R0 232 (76.6%)
R1 71 (23.4%)
MRI, magnetic resonance imaging; PET, positron emission tomography; BMI, body mass index; ASA, American Society of Anesthesiologists; RFA, radiofrequency ablation.
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0.21–7.36 years) in the most deprived categories (P = 0.511). The
median number of surveillance scans performed was three (range:
one to nine) in both the least and most deprived groups (P =
0.938). Tumour recurrence occurred in 163 patients; there was
no difference in recurrence rate [77/133 (57.9%) versus 30/50
(60.0%); P = 0.867] or median time to recurrence between
patients in the two least deprived (0.56 years; range: 0.14–2.74
years) and two most deprived (0.61 years; range: 0.21–3.91 years)
categories (P = 0.305). There was no difference among the disease-
free survival curves for each category of SES (P = 0.913) (Fig. 1).
Among those patients who underwent planned curative resec-
tions and for whom socioeconomic data were available, including
those in whom no surveillance imaging was performed (n = 277),
there were a total of 96 deaths during the study period (34.7%).
There was no significant difference in mortality rate between
patients in the two least deprived categories (42/136, 30.9%) and
those in the two most deprived categories (18/53, 34.0%) (P =
0.729). Twelve patients died within 90 days of surgery (4.3%), but
there was no significant difference in 90-day mortality between
patients in the two least deprived (4/136, 2.9%) and those in the
two most deprived (3/53, 5.7%) categories (P = 0.403). There was
no difference in overall survival curves across categories of SES
(P = 0.190) (Fig. 2).
Multivariate analysis of factors potentially associated with
tumour recurrence (Table 4) demonstrated no association
between SES and tumour recurrence (P = 0.700). Only the
number of liver metastases (P = 0.014) and maximum tumour
diameter (P = 0.001) were associated with tumour recurrence.
Each additional liver metastasis increased the risk for recurrence
by a factor of 1.28, and each additional millimetre in tumour
diameter had a small effect, increasing the risk for recurrence by a
factor of 1.02.
Discussion
The principal finding of this study is that the SES of patients
undergoing liver resection for CLM is not representative of that of
the local population because the proportion of patients from the
least deprived categories is higher than expected and that of
patients from the most deprived categories is lower than expected.
Amongst patients undergoing liver resection for CLM, the degree
of socioeconomic deprivation had no effect on tumour recurrence
after resection.
The finding that people from the least deprived categories of
SES account for a higher proportion of patients undergoing liver
surgery for CLM than they do in the local population is significant
and in keeping with the present authors’ clinical observations. The
comparison is subject to bias as the incidence of colorectal cancer
is influenced by SES and the disease is more common in popula-
tions with greater levels of deprivation.1 This would tend therefore
to increase the differences observed in the proportions of the
different population categories submitted to liver surgery in com-
parison with those within the local population because CLM
would be expected to occur more commonly amongst patients of
lower SES. There are many potential reasons why patients with the
least deprivation are more likely to undergo surgery for CLM,
despite being at lower risk for the development of colorectal
cancer. Patients with higher levels of deprivation are more likely to
suffer postoperative complications and death following primary
colorectal cancer surgery16 and are likely to have more or more
severe comorbidities that render them unfit for further surgery.
Socioeconomic status is associated with educational attainment,17
and patients with greater deprivation may be less aware of the
potential benefits of treatment for metastatic disease. This may
affect patients’ willingness to engage with longterm surveillance to
detect metachronous disease and to seek referral to an HPB unit.
There is also an element of discretion by clinical practitioners in
many stages of the patient pathway prior to surgery for CLM,
which may be influenced by perceptions of degree of socioeco-
nomic deprivation.
Interestingly, there was a large disparity in the use of staging
PET scans, which were performed in 74.5% of patients from the
least deprived groups compared with only 30.4% of patients from
the most deprived. This may be partly explained by the higher
incidence of T4 primary tumours amongst the least deprived
patients, which is one of the indications for PET scans in national
guidelines,6 but is not otherwise explicable by the other measures
of disease burden used in this study.
Table 2 Distribution of population categorized by socioeconomic status in the UK, and in Devon and Cornwall, and in those undergoing liver
resection for colorectal liver metastases. Socioeconomic status was unclassified for eight patients. (Comparison between the proportion of
residents of Devon and Cornwall and those undergoing liver resection: P < 0.001)
Deprivation category UK residents, n (%) Residents of Devon
and Cornwall, n (%)
Patients undergoing
liver resection, n (%)
1 Wealthy achievers (least deprived) 14 967 871 (24.8%) 580 065 (34.6%) 137 (46.4%)
2 Urban prosperous 7 594 891 (12.6%) 93 708 (5.6%) 11 (3.7%)
3 Comfortably off 16 656 466 (27.6%) 497 182 (29.7%) 93 (31.5%)
4 Moderate means 8 449 324 (14.0%) 271 357 (16.2%) 31 (10.5%)
5 Hard-pressed (most deprived) 12 715 861 (21.1%) 232 757 (13.9%) 23 (7.8%)
Total 60 384 413 1 676 069 295
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Table 3 Preoperative and operative characteristics of the 148 least (categories 1 and 2) and 54 most (categories 4 and 5) socioeconomically
deprived patients undergoing liver resection for colorectal liver metastases
Least deprived patients Most deprived patients
Categories 1 + 2 (n = 148) Categories 4 + 5 (n = 54) P-value
Age, years, median (range) 67 (34–88) 67 (33–90) 0.562
Gender, n (%) Female 56 (37.8%) 23 (42.6%) 0.625
Male 92 (62.2%) 31 (57.4%)
T stage of primary, n (%) 0 2 (1.4%) 0 0.060
1 4 (2.7%) 1 (1.9%)
2 12 (8.1%) 2 (3.7%)
3 71 (48.0%) 39 (72.2%)
4 52 (35.1%) 11 (20.4%)
Unavailable 7 (4.7%) 1 (1.9%)
N stage of primary, n (%) 0 64 (43.2%) 24 (44.4%) 0.781
1 50 (33.7%) 16 (29.6%)
2 30 (20.3%) 13 (24.1%)
Unavailable 4 (2.7%) 1 (1.9%)
Site of primary, n (%) Colonic 77 (52.0%) 29 (53.7%) 0.874
Rectal 71 (48.0%) 25 (46.3%)
Timing Synchronous 71 (48.0%) 21 (38.9%) 0.268
Metachronous 77 (52.0%) 33 (61.1%)
Preoperative MRI, n (%) Yes 83 (56.1%) 29 (53.7%) 0.873
No 65 (43.9%) 25 (46.3%)
Preoperative PET, n (%) Yes 111 (75.0%) 25 (46.3%) <0.001
No 37 (25.0%) 29 (53.7%)
Preoperative liver-directed chemotherapy, n (%) Yes 77 (52.0%) 25 (46.3%) 0.526
No 71 (48.0%) 29 (53.7%)
Preoperative diabetes, n (%) Yes 16 (10.8%) 3 (5.6%) 0.413
No 132 (89.2%) 51 (94.4%)
BMI, kg/m2, median (range) 27 (17–39) 27 (19–54) 0.859
ASA class, n (%) 1 16 (10.8%) 1 (1.9%) 0.030
2 104 (70.3%) 36 (66.7%)
3 28 (18.9%) 17 (31.5%)
Neutrophil : lymphocyte ratio, median (range) 2.38 (0.50–10.10) 2.85 (0.94–17.25) 0.161
Preoperative albumin, g/dl, median (range) 44 (29–51) 43 (34–51) 0.102
POSSUM physiological score, median (range) 16 (12–32) 17 (13–30) 0.720
RFA included, n (%) Yes 11 (7.4%) 4 (7.4%) 1.000
No 137 (92.6%) 50 (92.6%)
Wedge resection included, n (%) Yes 68 (45.9%) 21 (38.9%) 0.425
No 80 (54.1%) 33 (61.1%)
Number of segments resected, median (range) 4 (1–6) 3 (1–6) 0.617
Repeat operation, n (%) Yes 15 (10.1%) 4 (7.4%) 0.786
No 133 (89.9%) 50 (92.6%)
Curative resection, n (%) Yes 136 (91.9%) 53 (98.1%) 0.191
No 12 (8.1%) 1 (1.9%)
Number of liver metastases, median (range) 2 (1–10) 1 (1–8) 0.317
Maximum diameter of metastases, mm, median (range) 30 (3–120) 35 (5–120) 0.063
Resection margin, n (%) R0 115 (77.7%) 44 (81.5%) 0.698
R1 33 (22.3%) 10 (18.5%)
MRI, magnetic resonance imaging; PET, positron emission tomography; BMI, body mass index; ASA, American Society of Anesthesiologists; RFA,
radiofrequency ablation.
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There was no difference in objective measures of health
between patients in the highest and lowest categories of SES, as
shown by the presence of preoperative diabetes, physiological
score or body mass index. This may reflect the greater selection of
patients from more deprived groups, in whom the rate of these
markers of poor health might be expected to be higher. There was,
however, a small difference in subjective measures of health as
determined by ASA grade.
To categorize SES, this study used the ACORN® system, which
has been used in a number of epidemiological studies.18–21 This
system has advantages in that economic data are drawn from a
wide range of sources in addition to property values. Other studies
addressing the influence of SES on health care outcomes have used
the income domain of the Index of Multiple Deprivation (IMD)
score22 and the Townsend index.23 These systems have been used
simultaneously in previous studies24,25 and neither method has
Figure 1 Kaplan–Meier curves for disease-free survival in 303 patients with colorectal liver metastases submitted to liver resection stratified
according to socioeconomic status. Categories 1–5 represent, respectively: wealthy achievers; the urban prosperous; the comfortably off;
those of moderate means, and the hard-pressed
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been shown to be superior. Moreover, the difficulties of analysing
and interpreting socioeconomic data have been described.26
However, the systems allow for the valid and simultaneous com-
parison of different populations in contexts in which potential
bias and inaccuracy will affect the populations under study
equally.
In a manner reflecting the findings of previous work,8 degree of
socioeconomic deprivation was not shown to be associated with
either 90-day mortality or disease recurrence. The most likely
explanation for this to be derived from the present data is not that
SES does not affect these outcomes, but that greater selection
occurs amongst patients of lower SES to favour patients who are
likely to have better outcomes.
The difference in the rates of liver resection for CLM according
to SES may reflect selection on the basis of objective health meas-
ures. However, further study is required to confirm this and to
Figure 2 Kaplan–Meier curves for overall survival in 303 patients with colorectal liver metastases submitted to liver resection stratified
according to socioeconomic status. Categories 1–5 represent, respectively: wealthy achievers; the urban prosperous; the comfortably off;
those of moderate means, and the hard-pressed
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Table 4 Univariate and multivariate analyses of factors associated with tumour recurrence following liver resection for colorectal liver
metastases in 266 patients
Univariate analysis Multivariate analysis
Not recurred
(n = 103)
Recurred
(n = 163)
P-value Odds ratio
(95% CI)
P-value Odds ratio
(95% CI)
Agea, years, median (range) 65 (36–88) 67 (33–87) 0.872
Gender, n (%) Male 67 (65.0%) 105 (64.4%) 0.863
Female 36 (35.0%) 58 (35.6%)
SES category, n (%) 1 (least
deprived)
52 (50.5%) 74 (45.4%) 0.700
2 4 (3.9%) 3 (1.8%)
3 27 (26.2%) 56 (34.4%)
4 11 (10.7%) 19 (11.7%)
5 (most
deprived)
9 (8.7%) 11 (6.7%)
T stage of primary, n (%) 0, 1 or 2 10 (9.7%) 18 (11.0%) 0.147b 0, 1, 2
versus 3
0.504 0.79
(0.40–1.56)
3 61 (59.2%) 93 (57.1%) 3 versus 4 0.706 1.11
(0.68–1.80)4 29 (28.2%) 47 (28.8%)
N stage of primary, n (%) 0 50 (48.5%) 67 (41.1%) 0.828
1 34 (33.0%) 53 (32.5%)
2 18 (17.5%) 40 (24.5%)
Site of primary colorectal
tumour, n (%)
Colon 55 (53.4%) 75 (46.0%) 0.389
Rectum 48 (46.6%) 88 (54.0%)
Timing, n (%) Synchronous 46 (44.7%) 78 (47.9%) 0.584
Metachronous 57 (55.3%) 85 (52.1%)
Preoperative chemotherapy, n (%) 47 (45.6%) 85 (52.1%) 0.412
Preoperative diabetes, n (%) 7 (6.8%) 15 (9.2%) 0.523
BMI, kg/m2a, median (range) 27 (19–54) 27 (16–50) 0.518
ASA class, median (range) 2 (1–3) 2 (1–3) 0.566
Preoperative albumin, g/dla, median (range) 44 (34–50) 44 (26–52) 0.949
POSSUM physiological scorea, median (range) 17 (12–32) 16 (12–32) 0.378
Neutrophil : lymphocyte ratio (preop)a, median
(range)
2.4
(0.5–17.3)
2.6 (0.7–9.1) 0.211b 1.09
(0.95–1.26)
0.079 1.09
(0.94–1.28)
Preoperative MRI, n (%) 59 (57.3%) 87 (53.4%) 0.640
Preoperative PET, n (%) 68 (66.0%) 110 (67.5%) 0.930
Wedge resection included, n (%) 31 (30.1%) 67 (41.1%) 0.117b 0.062 1.70
(0.98–2.94)
RFA included, n (%) 6 (5.8%) 10 (6.1%) 0.959
Number of segments resecteda, median
(range)
4 (1–6) 4 (1–6) 0.222b 1.10
(0.94–1.28)
0.120 1.00
(0.94–1.07)
Repeat operation, n (%) 11 (10.7%) 18 (11.0%) 0.105b 0.824 1.04
(0.39–2.77)
Number of tumoursa, median (range) 1 (1–7) 2 (1–10) 0.007b 1.29
(1.07–1.55)
0.014 1.28
(1.06–1.56)
Largest tumour diameter, mma, median (range) 28 (3–155) 35 (6–150) 0.002b 1.02
(1.01–1.03)
0.001 1.02
(1.00–1.04)
Resection margin <1 mm (R1), n (%) 18 (17.5%) 45 (21.2%) 0.212b 0.372 1.03
(0.94–1.07)
aIn univariate analysis continuous variables were tested with logistic regression. Categorical variables were tested with the chi-squared test.
bSignificant at the level of <0.25 for univariate analysis and tested in multivariate analysis.
95% CI, 95% confidence interval; SES, socioeconomic status; BMI, body mass index; ASA, American Society of Anesthesiologists; MRI, magnetic
resonance imaging; PET, positron emission tomography; RFA, radiofrequency ablation.
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ensure equity of access to specialized hepatobiliary services within
a publicly funded health care system. Similar differences may be
found in other countries, especially those with systems of pre-
dominantly private health insurance, and the selection of patients
for surgery on the basis of SES may influence the comparison of
outcomes between countries.
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